Brivaracetam impurity 110 CAS 1997309-40-6

Purity 97%+In StockPharmacopoeial Impurity Standards
CAS No.1997309-40-6
Molecular FormulaC12H22O4
Molecular Weight230.30 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Brivaracetam impurity 110 CAS 1997309-40-6 chemical structure

Description

CATO supplies Brivaracetam impurity 110 (CAS 1997309-40-6), a pharmacopoeial impurity reference standard (molecular formula C12H22O4, MW 230.30 g/mol) used for the identification and quantification of trace impurities in APIs.

The molecular framework of Brivaracetam impurity 110 (C12H22O4) is characterized by a carboxylic acid group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by its high hydrophobicity (logP), which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The high carbon-to-hydrogen ratio imparts good lipophilicity, allowing liquid-liquid extraction with non-polar solvents such as n-hexane or ethyl acetate.

Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.

The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.

Physical & Chemical Properties

Molecular FormulaC12H22O4
Molecular Weight230.30 g/mol
Purity97%+
StorageStore in a cool place (≤25°C), keep sealed and dry
Solubility (reference)Soluble in chloroform, dichloromethane, ethyl acetate, DMSO
StabilityHygroscopic; reseal immediately after opening
Degree of Unsaturation (DBE)2.0
CAS Registry Year (est.)1996

Related Brivaracetam Standards

Recommended Standards

Why CATO?